Peak Pharmaceuticals, Inc. Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended June 30, 2015
For the nine months, the company reported revenues of $751,313. Net loss was $1,893,779 against $2,492,464 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.5 USD | -13.46% | -13.46% | +160.12% |
1st Jan change | Capi. | |
---|---|---|
+160.12% | 94.16M | |
+11.75% | 3,123B | |
+10.06% | 86.45B | |
+6.04% | 78.6B | |
-14.66% | 53.98B | |
+26.73% | 48.46B | |
-24.44% | 46.78B | |
+31.74% | 46.36B | |
+82.12% | 42.36B | |
-8.15% | 25.22B |